The menopause peptide guide covers compounds that may support hormonal balance during this transition
It is important to recognise that patients prescribed GLP-1 agonists often have underlying conditionssuch as type 2 diabetes, obesity, hypertension, and dyslipidaemiathat independently increase cardiovascular and thrombotic risk
About 89.5% of those continuing tirzepatide maintained at least 80% of their lead-in weight loss versus 16.6% of those who switched to placebo
In a pooled analysis of phase 2 and 3a clinical trials of liraglutide for weight management, when administered once daily at a dose of 3.0 mg caused no major concerns regarding its neuropsychiatric safety [123]
For more information or to discuss ipamorelin with others, join a support group or speak with a trusted healthcare professional
Compounders are damaging our business, CEO Lars Fruergaard Jorgensen told investors at the time, adding that once the copycat drugs go off the market in May, I sincerely hope many of those patients will then come back to Novo Nordisk.